Antonio Rescifina Selected Research

Antonio Rescifina Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 01/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 10/2018
2	COVID-19 03/2022 - 04/2020
2	Pain (Aches) 01/2022 - 12/2019
2	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2020
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2019
2	Botulism 12/2020 - 01/2020
2	Inflammation (Inflammations) 01/2019 - 09/2017
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 12/2017
1	Dehydration (Water Stress) 01/2020
1	Migraine Disorders (Migraine) 01/2020
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Fatigue 01/2020
1	Chronic Pain 12/2019
1	Hyperglycemia 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Melanoma (Melanoma, Malignant) 05/2018
1	Leishmaniasis 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2017
1	Atherosclerosis 09/2017
1	Glioma (Gliomas) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Polyploidy 07/2010
1	Infections 07/2009
1	T-Cell Leukemia (Leukemia, T Cell) 07/2007

Drug/Important Bio-Agent (IBA)

4	LigandsIBA 01/2022 - 01/2017
4	Heme Oxygenase-1IBA 01/2021 - 10/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2011
4	Intercalating AgentsIBA 01/2018 - 01/2011
3	Pharmaceutical PreparationsIBA 03/2022 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021 - 05/2018
3	Histone Deacetylase InhibitorsIBA 02/2019 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 10/2018
2	EnzymesIBA 04/2019 - 10/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 09/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 12/2017
2	ProdrugsIBA 10/2017 - 01/2015
2	Haloperidol (Haldol)FDA LinkGeneric 10/2017 - 01/2015
2	Biological ProductsIBA 01/2015 - 07/2009
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 05/2012 - 01/2011
1	AmidesIBA 12/2021
1	benzothiazoleIBA 12/2021
1	Acarbose FDA LinkGeneric 12/2021
1	Heme (Haem)IBA 01/2021
1	incobotulinumtoxinA FDA Link 12/2020
1	Type A Botulinum Toxins (Botox)FDA Link 12/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 05/2020
1	PyrrolesIBA 05/2020
1	polypropylene glycol (poly(propylene oxide))IBA 05/2020
1	NitratesIBA 05/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2020
1	Lopinavir FDA Link 04/2020
1	HIV Protease InhibitorsIBA 04/2020
1	Hormones (Hormone)IBA 03/2020
1	cucurbit(7)urilIBA 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2020
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2019
1	Opioid Analgesics (Opioids)IBA 12/2019
1	AntioxidantsIBA 01/2019
1	GlucosidasesIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	PolyphenolsIBA 01/2019
1	Rosmarinic AcidIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Imatinib Mesylate (Gleevec)FDA Link 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Cysteine Proteases (Cysteine Protease)IBA 01/2018
1	2- (2- methoxybenzyl)- 3- (1,10- phenanthrolin- 2- yl)isoxazolidin- 5- yl)methanolIBA 01/2018
1	benzimidazoleIBA 01/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2017
1	Vorinostat FDA Link 11/2017
1	romidepsin (FK228)FDA Link 11/2017
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 09/2017
1	Niacin (Nicotinic Acid)FDA LinkGeneric 09/2017
1	QuinoxalinesIBA 09/2017
1	Urea (Carbamide)FDA LinkGeneric 09/2017
1	quinolineIBA 09/2017
1	pyridineIBA 09/2017
1	Artificial Membranes (Artificial Membrane)IBA 01/2015
1	AnthraquinonesIBA 03/2014
1	Alkylating AgentsIBA 03/2014
1	AnthracyclinesIBA 03/2014
1	AcridinesIBA 03/2014
1	IsoxazolesIBA 05/2012
1	calf thymus DNAIBA 01/2011
1	ResveratrolIBA 07/2010
1	NucleosidesIBA 07/2009
1	pyrrolidineIBA 07/2009
1	Antiviral Agents (Antivirals)IBA 07/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2009
2	Drug Therapy (Chemotherapy) 01/2018 - 03/2014
1	Photochemotherapy (Photodynamic Therapy) 12/2017